MASECO Private Wealth’s AbbVie ABBV Stock Holding History

MASECO Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Sell	5,446 -29	-0.5%	-$6.24K	0.04%	58
2026 Q1	$1.19M	Sell	5,475 -36	-0.7%	-$7.99K	0.04%	57
2025 Q4	$1.26M	Sell	5,511 -2,780	-34%	-$633K	0.05%	51
2025 Q3	$1.92M	Buy	8,291 +1,000	+14%	+$204K	0.09%	30
2025 Q2	$1.35M	Buy	+7,291	New	+$1.36M	0.05%	56

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

MASECO Private Wealth's ABBV Position: Q2 2026 in Review

MASECO Private Wealth reduced its AbbVie (ABBV) stake by 0.53% in Q2 2026, selling an estimated $6.24K and leaving 5,446 shares worth $1.37M. The position accounts for 0.04% of the portfolio, ranked #58.

MASECO Private Wealth first reported a position in ABBV in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.92M in Q3 2025. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

MASECO Private Wealth held 5,446 shares of AbbVie worth $1.37M as of Q2 2026.
MASECO Private Wealth sold 29 AbbVie shares in Q2 2026, an estimated $6.24K.
AbbVie made up 0.04% of MASECO Private Wealth's portfolio in Q2 2026, its #58 holding.
MASECO Private Wealth first reported a position in AbbVie in Q2 2025 and has held it in 5 quarters since.
MASECO Private Wealth's AbbVie position peaked at $1.92M in Q3 2025.
4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on MASECO Private Wealth's 13F filing for Q2 2026, filed 5 Aug 2026.